| Literature DB >> 28397757 |
Li-Mei Dong1,2,3, Mei Zhang4, Qiao-Lin Xu5, Qiang Zhang6,7, Bi Luo8,9, Qing-Wen Luo10,11, Wen-Bin Liu12,13, Jian-Wen Tan14,15.
Abstract
Two new thymol derivatives, 7,9-diisobutyryloxy-8-ethoxythymol (1) and 7-acetoxy-8-methoxy-9-isobutyryloxythymol (2), were isolated from fresh roots of Ageratina adenophora, together with four known compounds, 7,9-di-isobutyryloxy-8-methoxythymol (3), 9-oxoageraphorone (4), (-)-isochaminic acid (5) and (1α,6α)-10-hydroxycar-3-ene-2-one (6). Their structures were established on the basis of detailed spectroscopic analysis, and they were all isolated from the roots of A. adenophora for the first time. All the compounds were tested for their in vitro antibacterial activity toward three Gram-positive and two Gram-negative bacterial strains. Thymol derivatives 1-3 only selectively showed slight in vitro bacteriostatic activity toward three Gram-positive bacteria. The two known carene-type monoterpenes 5 and 6 were found to show moderate in vitro antibacterial activity against all five tested bacterial strains, with MIC values from 15.6 to 62.5 μg/mL. In addition, compounds 5 and 6 were further revealed to show in vitro cytotoxicity against human tumor A549, HeLa and HepG2 cell lines, with IC50 values ranging from 18.36 to 41.87 μM. However, their cytotoxic activities were inferior to those of reference compound adriamycin.Entities:
Keywords: Ageratina adenophora; antibacterial; cytotoxicity; monoterpenes; thymol derivatives
Mesh:
Substances:
Year: 2017 PMID: 28397757 PMCID: PMC6154539 DOI: 10.3390/molecules22040592
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of compounds 1−6.
The 1H- and 13C-NMR data of compounds 1, 2 and 3.
| H/C | 1 a | 2 a | 3 b | |||
|---|---|---|---|---|---|---|
| δH (Mult., | δC (DEPT) | δH (Mult., | δC (DEPT) | δH (Mult., | δC (DEPT) | |
| 1 | 138.2 (s) | 137.9 (s) | 138.3 (s) | |||
| 2 | 6.84 (d, 1.2) | 116.3 (d) | 6.85 (s) | 116.6 (d) | 6.86 (s) | 116.4 (d) |
| 3 | 156.5 (s) | 156.4 (s) | 156.4 (s) | |||
| 4 | 124.4 (s) | 123.8 (s) | 123.6 (s) | |||
| 5 | 7.01 (d, 8.0) | 127.6 (d) | 7.01 (d, 8.4) | 127.8 (d) | 7.02 (d, 8.4) | 127.9 (d) |
| 6 | 6.82 (dd, 8.0, 1.2) | 118.8 (d) | 6.82 (d, 8.4) | 119.2 (d) | 6.83 (d, 8.4) | 119.0 (d) |
| 7 | 5.04 (s) | 65.3 (t) | 5.03 (s) | 65.5 (t) | 5.05 (s) | 65.3 (t) |
| 8 | 80.8 (s) | 81.3 (s) | 81.4 (s) | |||
| 9 | 4.36 (d, 11.6) | 68.3 (t) | 4.33 (d, 12.0) | 68.2 (t) | 4.34 (d, 11.6) | 68.3 (t) |
| 4.23 (d, 11.6) | 4.22 (d, 12.0) | 4.23 (d, 11.6) | ||||
| 10 | 1.66 (s) | 21.0 (q) | 1.64 (s) | 20.2 (q) | 1.65 (s) | 20.2 (q) |
| 11 | 3.54 (m), 3.39 (m) | 59.1 (t) | 3.28 (s) | 50.9 (q) | 3.29 (s) | 51.0 (q) |
| 12 | 1.25 (t, 7.2) | 15.4 (q) | ||||
| 1′ | 176.6 (s) | 170.8 (s) | 176.6 (s) | |||
| 2′ | 2.56 (m) | 34.0 (d) | 2.10 (s) | 20.9 (q) | 2.60 (m) | 33.9 (d) |
| 3′ | 1.20 (d, 6.8) | 19.0 (q) | 1.20 (d, 6.8) | 18.8 (q) | ||
| 4′ | 1.20 (d, 6.8) | 19.0 (q) | 1.20 (d, 6.8) | 18.9 (q) | ||
| 1“ | 176.9 (s) | 176.5 (s) | 176.9 (s) | |||
| 2“ | 2.62 (m) | 34.0 (d) | 2.55 (m) | 33.9 (d) | 2.60 (m) | 34.0 (d) |
| 3“ | 1.13 (d, 6.8) | 18.9 (q) | 1.12 (d, 6.6) | 18.8 (q) | 1.12 (d, 6.8) | 18.9 (q) |
| 4“ | 1.13 (d, 6.8) | 18.9 (q) | 1.13 (d, 6.6) | 18.8 (q) | 1.13 (d, 6.8) | 20.2 (q) |
Recorded in CDCl3; b Recorded in CD3OD.
Figure 2Selected HMBC () and COSY () correlations of compounds 1 and 2.
MIC values of compounds 1–6 in μg/mL against five bacterial strains.
| Compounds | |||||
|---|---|---|---|---|---|
| >200 | >200 | 125 | >200 | >200 | |
| 125 | 62.5 | 62.5 | >200 | >200 | |
| >200 | 125 | 125 | >200 | >200 | |
| >200 | >200 | >200 | >200 | >200 | |
| 31.3 | 31.3 | 15.6 | 62.5 | 62.5 | |
| 15.6 | 31.3 | 15.6 | 62.5 | 62.5 | |
| KS | 3.9 | 3.9 | 3.9 | 3.9 | 3.9 |
| C | >200 | >200 | >200 | 7.8 | 7.8 |
KS = Kanamycin sulfate, C = Cefradine.
Cytotoxicity of compounds 1–6 (IC50, µM).
| Compounds | A549 | HeLa | HepG2 |
|---|---|---|---|
| >100 | >100 | >100 | |
| 32.37 ± 3.75 | 25.64 ± 2.34 | 41.87 ± 6.53 | |
| 30.65 ± 3.87 | 18.36 ± 1.72 | 39.44 ± 3.61 | |
| Adriamycin | 0.68 ± 0.06 | 0.46 ± 0.05 | 1.23 ± 0.02 |
Values represent mean ± SD (n = 3) based on three individual experiments.